Form 4: Jazz Pharmaceuticals Executive Reports Stock Transaction
Insider Transaction (Form 4)
Samantha Pearce, EVP, Chief Commercial Officer of Jazz Pharmaceuticals plc, reported a transaction in 780 shares of common stock on August 5, 2026.
Summary
- Tax/exercise-price withholding: disposed of 780 Ordinary Shares at $261.62 ($204,064) on August 5, 2026; holds 47,131 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Samantha Pearce — Officer (EVP, Chief Commercial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-05 | Tax/exercise-price withholding | Ordinary Shares | 780 | $262 | $204.1K | 47,131 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-05 | Tax/exercise-price withholding (780 shares) |
Keywords
insider transaction, Form 4, JAZZ, Jazz Pharmaceuticals plc, neutral, Samantha Pearce
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.